Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erina Paul

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Toxicologic Pathology|May 14, 2024
Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in RatsYi-Zhong Gu, Erina Paul, Katerina Vlasakova, et al.
Clinical Pharmacology and Therapeutics|July 25, 2020
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal ImpairmentDaniel A Tatosian, Ka Lai Yee, Zufei Zhang, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Toxicologic Pathology|May 14, 2024
Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in RatsYi-Zhong Gu, Erina Paul, Katerina Vlasakova, et al.
Clinical Pharmacology and Therapeutics|July 25, 2020
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal ImpairmentDaniel A Tatosian, Ka Lai Yee, Zufei Zhang, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
Pageof 2